Replies to post #1215 on NorthWest Biotherapeutics Inc (NWBO)

[john1045]

MJ...this is definitely very positive and this is significant in that anyone who is diagnosed with inoperable tumor, solid tissue tumor as noted in the PR affects a significant part of the patient population suffering from these types of cancers. Their enrollment of this trial will be rapid considering all of the locations and DCVax strong acceptance from the sites will complete end of enrollment pretty quickly unless they increase from 36 to larger population due to demand. The market for the DCVAX-Direct in US and Europe is massive if the results are similar or better to the earlier trial years ago. I believe we will have more news coming with update on Germany and England and possible enrollment update with another PR. GLTA!